Add new comment

I'm not working at the moment https://www.amgwealth.com/stmap_37lbquli.html?analgin.cialis.dinitrate.d... losartan tablets ip 50 mg Novartis expects 2013 to be a year of transition as it bearsthe full brunt of last year's patent loss on Diovan. It iscounting on sales of new products like cancer drug Afinitor andmultiple sclerosis pill Gilenya to fill the gap. (Reporting by Caroline Copley)